Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
Zacks.com on MSN2h
Biogen Gears Up to Report Q4 Earnings: What's in the Cards?Biogen BIIB will report fourth-quarter and full-year 2024 results on Feb. 12, before market open. In the last reported ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...
17hon MSN
The global chemical maker Bayer is backing an expanded effort to shield itself from lawsuits alleging its popular weedkiller ...
This eBook celebrates the achievements of inspiring women in life sciences, highlighting their journeys, challenges and ...
If this medication contains a substance or requires an administration method that is on the List of Prohibited Substances and Methods (List), you may apply for a Therapeutic Use Exemption (TUE). A TUE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback